For a small percentage of patients – especially those whose cancer has spread – doctors can struggle to pinpoint where the tumor originated from.
This makes it much more difficult to choose a treatment for those patients, because many cancer drugs are typically developed for specific cancer types. The Daily Mail
See also:
No comments:
Post a Comment